Chemical Formula: C6H9NO5

Chemical Formula C6H9NO5

Found 28 metabolite its formula value is C6H9NO5

N-Acetyl-L-aspartic acid

N-Acetylaspartate, monopotassium salt

C6H9NO5 (175.0480704)


N-Acetyl-L-Aspartic acid (NAA) or N-Acetylaspartic acid, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-alpha-Acetyl-L-aspartic acid can also be classified as an alpha amino acid or a derivatized alpha amino acid. Technically, N-Acetyl-L-aspartic acid is a biologically available N-terminal capped form of the proteinogenic alpha amino acid L-aspartic acid. N-acetyl amino acids can be produced either via direct synthesis of specific N-acetyltransferases or via the proteolytic degradation of N-acetylated proteins by specific hydrolases. N-terminal acetylation of proteins is a widespread and highly conserved process in eukaryotes that is involved in protection and stability of proteins (PMID: 16465618). About 85\\\% of all human proteins and 68\\\% of all yeast proteins are acetylated at their N-terminus (PMID: 21750686). Several proteins from prokaryotes and archaea are also modified by N-terminal acetylation. The majority of eukaryotic N-terminal-acetylation reactions occur through N-acetyltransferase enzymes or NAT’s (PMID: 30054468). These enzymes consist of three main oligomeric complexes NatA, NatB, and NatC, which are composed of at least a unique catalytic subunit and one unique ribosomal anchor. The substrate specificities of different NAT enzymes are mainly determined by the identities of the first two N-terminal residues of the target protein. The human NatA complex co-translationally acetylates N-termini that bear a small amino acid (A, S, T, C, and occasionally V and G) (PMID: 30054468). NatA also exists in a monomeric state and can post-translationally acetylate acidic N-termini residues (D-, E-). NatB and NatC acetylate N-terminal methionine with further specificity determined by the identity of the second amino acid. N-acetylated amino acids, such as N-acetylaspartate can be released by an N-acylpeptide hydrolase from peptides generated by proteolytic degradation (PMID: 16465618). In addition to the NAT enzymes and protein-based acetylation, N-acetylation of free aspartic acid can also occur. In particular, N-Acetyl-L-aspartic acid can be synthesized in neurons from the amino acid aspartate and acetyl coenzyme A (acetyl CoA). Specifically, the enzyme known as aspartate N-acetyltransferase (EC 2.3.1.17) catalyzes the transfer of the acetyl group of acetyl CoA to the amino group of aspartate. N-Acetyl-L-aspartic acid is the second most concentrated molecule in the brain after the amino acid glutamate. The various functions served by N-acetylaspartic acid are still under investigation, but the primary proposed functions include (1) acting as a neuronal osmolyte that is involved in fluid balance in the brain, (2) serving as a source of acetate for lipid and myelin synthesis in oligodendrocytes (the glial cells that myelinate neuronal axons), (3) serving as a precursor for the synthesis of the important dipeptide neurotransmitter N-acetylaspartylglutamate (NAAG), and (4) playing a potential role in energy production from the amino acid glutamate in neuronal mitochondria. High neurotransmitter (i.e. N-acetylaspartic acid) levels can lead to abnormal neural signaling, delayed or arrested intellectual development, and difficulties with general motor skills. When present in sufficiently high levels, N-acetylaspartic acid can be a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin is a compound that disrupts or attacks neural tissue. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of N-acetylaspartic acid are associated with Canavan disease. Because N-acetylaspartic acid functions as an organic acid and high levels of organic acids can lead to a condition known... N-Acetylaspartic acid is a derivative of aspartic acid. It is the second most concentrated molecule in the brain after the amino acid glutamate. It is synthesized in neurons from the amino acid aspartate and acetyl coenzyme A. The various functions served by N-acetylaspartic acid are still under investigation, but the primary proposed functions include: Acquisition and generation of the data is financially supported in part by CREST/JST. D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids KEIO_ID A142 N-Acetyl-L-aspartic acid is a derivative of aspartic acid.

   

N-Formyl-L-glutamic acid

(2S)-2-(Formylamino)pentanedioic acid

C6H9NO5 (175.0480704)


N-Formyl-L-glutamate is an intermediate in the histidine metabolism, in a reaction mediated by the enzyme formiminotransferase cyclodeaminase [EC:2.1.2.5 4.3.1.4], a bifunctional enzyme that channels 1-carbon units from formiminoglutamate to the folate pool.(KEGG) [HMDB] N-Formyl-L-glutamate is an intermediate in the histidine metabolism, in a reaction mediated by the enzyme formiminotransferase cyclodeaminase [EC:2.1.2.5 4.3.1.4], a bifunctional enzyme that channels 1-carbon units from formiminoglutamate to the folate pool.(KEGG).

   

2-Amino-3-oxoadipate

2-amino-3-oxo-hexanedioic acid

C6H9NO5 (175.0480704)


This compound belongs to the family of Alpha Amino Acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon).

   

D-N-(Carboxyacetyl)alanine

2-[(2-Carboxy-1-hydroxyethylidene)amino]propanoate

C6H9NO5 (175.0480704)


D-N-(Carboxyacetyl)alanine is found in pulses. D-N-(Carboxyacetyl)alanine is isolated from seedlings of Pisum sativum (pea). Isolated from seedlings of Pisum sativum (pea). D-N-(Carboxyacetyl)alanine is found in pulses and common pea.

   

Alanine pyruvate

2-Aminopropanoyl 2-oxopropaneperoxoic acid

C6H9NO5 (175.0480704)


   

Dimethyloxalylglycine

methyl [(2-methoxy-2-oxoethyl)carbamoyl]formate

C6H9NO5 (175.0480704)


   

N-Acetylaspartic acid

N-Acetyl-DL-aspartic acid

C6H9NO5 (175.0480704)


   
   
   

N-acetyl-L-aspartic acid

N-acetyl-L-aspartic acid

C6H9NO5 (175.0480704)


An N-acyl-L-aspartic acid in which the acyl group is specified as acetyl. D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; OTCCIMWXFLJLIA-BYPYZUCNSA-N_STSL_0218_N-Acetyl-L-aspartic acid_2000fmol_190326_S2_LC02MS02_065; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. N-Acetyl-L-aspartic acid is a derivative of aspartic acid.

   

N-Acetyl-DL-aspartic acid

N-Acetyl-DL-aspartic acid

C6H9NO5 (175.0480704)


   

N-Acetylaspartate

N-acetyl-L-aspartic acid

C6H9NO5 (175.0480704)


N-Acetyl-L-aspartic acid is a derivative of aspartic acid.

   

N-Acetyl-aspartic acid; LC-tDDA; CE10

N-Acetyl-aspartic acid; LC-tDDA; CE10

C6H9NO5 (175.0480704)


   

N-Acetyl-aspartic acid; LC-tDDA; CE20

N-Acetyl-aspartic acid; LC-tDDA; CE20

C6H9NO5 (175.0480704)


   

N-Acetyl-aspartic acid; LC-tDDA; CE30

N-Acetyl-aspartic acid; LC-tDDA; CE30

C6H9NO5 (175.0480704)


   

N-Acetyl-aspartic acid; LC-tDDA; CE40

N-Acetyl-aspartic acid; LC-tDDA; CE40

C6H9NO5 (175.0480704)


   

N-ACETYL-ASPARTIC ACID

N-ACETYL-ASPARTIC ACID

C6H9NO5 (175.0480704)


   

D-N-(Carboxyacetyl)alanine

2-(2-carboxyacetamido)propanoic acid

C6H9NO5 (175.0480704)


   

Dimethyloxalylglycine

Dimethyloxalylglycine

C6H9NO5 (175.0480704)


DMOG (Dimethyloxallyl Glycine) is a cell permeable and competitive inhibitor of HIF-PH, which results in HIF-1α stabilisation and accmulation?in vitro and in vivo[1]. DMOG is an α-ketoglutarate analogue and inhibits α-KG-dependent hydroxylases. DMOG?acts as a pro-angiogenic agent and plays a protective role in experimental model of colitis and diarrhoea via HIF-1 related signal[2][4]. DMOG induces cell autophagy[5].

   

2-Amino-3-oxohexanedioic acid

2-amino-3-oxo-hexanedioic acid

C6H9NO5 (175.0480704)


   

N-Acetyl-D-aspartic acid

N-Acetyl-D-aspartic acid

C6H9NO5 (175.0480704)


   

Succinylglycine

Succinylglycine

C6H9NO5 (175.0480704)


   

Propanedioic acid, (methoxyimino)-, dimethyl ester

Propanedioic acid, (methoxyimino)-, dimethyl ester

C6H9NO5 (175.0480704)


   

N-acetyl-L-((13)C4)aspartic acid

N-acetyl-L-((13)C4)aspartic acid

C6H9NO5 (175.0480704)


   

N-formylisoglutamic acid

N-formylisoglutamic acid

C6H9NO5 (175.0480704)


   

3,4-Dihydroxy-5-(2-hydroxyethanimidoyl)oxolan-2-one

3,4-Dihydroxy-5-(2-hydroxyethanimidoyl)oxolan-2-one

C6H9NO5 (175.0480704)


   

N-formyl-L-glutamic acid

N-formyl-L-glutamic acid

C6H9NO5 (175.0480704)


   

2-Amino-3-oxoadipic acid

2-Amino-3-oxoadipic acid

C6H9NO5 (175.0480704)


A 1,6-dicarboxylic acid compound having an amino substituent at the 2-position and an oxo substituent at the 3-position.